Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE: 002603)

Market Cap	25.34B
Revenue (ttm)	8.13B
Net Income (ttm)	276.82M
Shares Out	1.67B
EPS (ttm)	0.17
PE Ratio	91.56
Forward PE	19.07
Dividend	0.30 (1.98%)
Ex-Dividend Date	Jul 19, 2024

Volume	5,233,000
Open	15.36
Previous Close	15.17
Day's Range	15.05 - 15.36
52-Week Range	14.46 - 27.25
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Shijiazhuang Yiling Pharmaceutical

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 13,958
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002603

Financial Performance

In 2023, Shijiazhuang Yiling Pharmaceutical's revenue was 10.32 billion, a decrease of -17.67% compared to the previous year's 12.53 billion. Earnings were 1.35 billion, a decrease of -42.76%.